Editas Medicine, Inc.
CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS

Last updated:

Abstract:

CRISPR/CAS-related systems, compositions and methods for editing RS1, RL2, and/or LAT genes in human cells are described, as are cells and compositions including cells edited according to the same.

Status:
Application
Type:

Utility

Filling date:

19 Apr 2021

Issue date:

13 Jan 2022